European Pharmacopoeia (EP) (Ph. Eur.) Solutions and Reagents

European Pharmacopoeia (EP) solutions and reagents ensure that pharmaceutical products meet the high-quality standards set by the European Union. These solutions are critical in testing the purity, potency, and quality of drugs. CymitQuimica offers a comprehensive range of Ph. Eur.-compliant solutions and reagents, supporting pharmaceutical research and quality control processes.

20
- 50
- 100
- 200

products per page. 9460 products on this category.

Product data	Purity	Price range	Estimated delivery
Sulfamethizole for system suitability CRS REF: 41-Y0002168	- - -	115.00 €	Wed 26 Mar 25
Levocetirizine dihydrochloride CRS REF: 41-Y0002401CAS: 130018-87-0	- - -	115.00 €	Wed 26 Mar 25
Olanzapine CRS REF: 41-Y0001370CAS: 132539-06-1	- - -	115.00 €	Wed 26 Mar 25
Loperamide hydrochloride RS REF: 41-ICRS0340CAS: 34552-83-5	- - -	102.00 €	Wed 26 Mar 25
Dienogest for system suitability CRS REF: 41-Y0001782CAS: 65928-58-7	- - -	115.00 €	Wed 26 Mar 25
Lavender oil for peak identification HRS REF: 41-Y0001992CAS: 1993-14-2	- - -	115.00 €	Wed 26 Mar 25
Mianserin hydrochloride CRS REF: 41-M1875000CAS: 21535-47-7	- - -	115.00 €	Wed 26 Mar 25
Amlodipine impurity A CRS REF: 41-Y0001068CAS: 88150-62-3	- - -	115.00 €	Wed 26 Mar 25
Methylthioninium chloride CRS REF: 41-M1800900CAS: 61-73-4	- - -	115.00 €	Wed 26 Mar 25
Norfloxacin for peak identification CRS REF: 41-Y0001301CAS: 70458-96-7	- - -	115.00 €	Wed 26 Mar 25
Beclometasone dipropionate impurities F and N CRS REF: 41-Y0001073	- - -	115.00 €	Wed 26 Mar 25
Gabapentin impurity A CRS REF: 41-Y0001281CAS: 64744-50-9	- - -	115.00 €	Wed 26 Mar 25
Amiloride for peak identification CRS REF: 41-Y0001902CAS: 17440-83-4	- - -	115.00 €	Wed 26 Mar 25
Acetylsalicylic acid for peak identification CRS REF: 41-Y0001460CAS: 50-78-2	- - -	115.00 €	Wed 26 Mar 25
Ramipril impurity B CRS REF: 41-R0145010CAS: 295328-72-2	- - -	115.00 €	Wed 26 Mar 25
Calcitonin-Gly CRS REF: 41-Y0000632	- - -	115.00 €	Wed 26 Mar 25
Febantel for system suitability CRS REF: 41-Y0000660CAS: 58306-30-2	- - -	115.00 €	Wed 26 Mar 25
Ginkgo dry extract for peak identification CRS REF: 41-Y0001012	- - -	115.00 €	Wed 26 Mar 25
Fosinopril impurity K CRS REF: 41-Y0001233	- - -	115.00 €	Wed 26 Mar 25
Cloxacillin sodium RS REF: 41-ICRS0261CAS: 7081-44-9	- - -	102.00 €	Wed 26 Mar 25

European Pharmacopoeia (EP) (Ph. Eur.) Solutions and Reagents

Sulfamethizole for system suitability CRS

Ref: 41-Y0002168

Levocetirizine dihydrochloride CRS

Ref: 41-Y0002401

Olanzapine CRS

Ref: 41-Y0001370

Loperamide hydrochloride RS

Ref: 41-ICRS0340

Dienogest for system suitability CRS

Ref: 41-Y0001782

Lavender oil for peak identification HRS

Ref: 41-Y0001992

Mianserin hydrochloride CRS

Ref: 41-M1875000

Amlodipine impurity A CRS

Ref: 41-Y0001068

Methylthioninium chloride CRS

Ref: 41-M1800900

Norfloxacin for peak identification CRS

Ref: 41-Y0001301

Beclometasone dipropionate impurities F and N CRS

Ref: 41-Y0001073

Gabapentin impurity A CRS

Ref: 41-Y0001281

Amiloride for peak identification CRS

Ref: 41-Y0001902

Acetylsalicylic acid for peak identification CRS

Ref: 41-Y0001460

Ramipril impurity B CRS

Ref: 41-R0145010

Calcitonin-Gly CRS

Ref: 41-Y0000632

Febantel for system suitability CRS

Ref: 41-Y0000660

Ginkgo dry extract for peak identification CRS

Ref: 41-Y0001012

Fosinopril impurity K CRS

Ref: 41-Y0001233

Cloxacillin sodium RS

Ref: 41-ICRS0261